The value of highly active antiretroviral therapy in the prevention of mother-to-child transmission of HIV

References

• ACOG. Committee opinion on scheduled caesarean delivery and the prevention of vertical transmission of HIV. No. 24. American College of Obstetricians and Gynecologists, Washington, DC 2000
   Google Scholar
• Beckerman K P, Morris A B, Stek A. Mode of delivery and the risk of vertical transmission of HIV-1. New England Journal of Medicine 1999; 341: 205–206
   PubMed Web of Science ®Google Scholar
• Blattner W, Cooper E, Charurat M, Thompson B, Hanson C, Mofenson L, et al. Effectiveness of potent antiretroviral therapies on reducing perinatal transmission of HIV-1 (Abstract LbOr4). XIII International AIDS conference, DurbanSouth Africa, 2000
   Google Scholar
• CDC. Recommendations of the US Public Health Service Task Force on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. Morbidity and Mortality Weekly Report 1994; RR-11: 1–21
   Google Scholar
• CDC. Recommendations for the use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal transmission in the United States. Morbidity and Mortality Weekly Report 2002; RR-18: 3–5
   Google Scholar
• Chama C M, Yahaya S J, Ajayi B B. The knowledge, attitude and practice of health workers towards people living with HIV/AIDS. Kanem Medical Journal, (in press)
   Google Scholar
• Coll O, Hernandez M, Boucher C AB. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. Journal of Acquired Immune Deficiency Syndrome 1997; 14: 26–30
   Google Scholar
• Conor E M, Sperling R S, Gelber R. Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment. New England Journal of Medicine 1994; 33: 1173–1180
   Google Scholar
• Cooper E R, Nugent R P, Diaz C. After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy and the subsequent reduction in vertical transmission of human immunodeficiency virus-1: a cohort of infected women and their infants. Journal of Infectious Diseases 1996; 174: 1207–1211
   PubMed Web of Science ®Google Scholar
• DoHHS. Recommendations for antiretroviral therapy in pregnancy. Department of Health and Human Services. 2003, Available at: http://www.aidsinfo.nih.gov
   Google Scholar
• FMoH. The National Seroprevalence Survey of HIV among antenatal women in 2003. Federal Ministry of Health, AbujaNigeria 2004
   Google Scholar
• FMoH. National Guideline on the Prevention of Mother-to-child Transmission of HIV, revised edition. Federal Ministry of Health, AbujaNigeria 2005
   Google Scholar
• FMoH. The National Seroprevalence Survey of HIV among antenatal women in 1998. Federal Ministry of Health, AbujaNigeria 1999
   Google Scholar
• Pipkin F B. Maternal physiology in pregnancy. Turnbull's obstetrics, G Chamberlain, P Steer. Churchill Livingstone, London 2001; 71–92
   Google Scholar
• Fortgang I S, Belitsos P C, Chaisson R E, Moore R D. Hepatomegaly and steatosis in HIV infected patients receiving nucleoside analogue antiretroviral therapy. American Journal of Gastroenterology 1995; 90: 1433–1436
   PubMed Web of Science ®Google Scholar
• Garcia P M, Kalish L A, Pitt J. Maternal levels of plasma human immunodeficiency virus typt-1 RNA and the risk of perinatal transmission. New England Journal of Medicine 1999; 341: 394–402
   PubMed Web of Science ®Google Scholar
• Gerard Y, Maulin L, Yadzanpanah Y. Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS 2000; 14: 2723–2730
   PubMed Web of Science ®Google Scholar
• Havlir D V, Richman D D. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Annals of Internal Medicine 1996; 124: 984–994
   PubMed Web of Science ®Google Scholar
• Helfgott A W, Erickson N, Lewis S, Doyle M, Pearson D, Bundrick C. Highly active antiretroviral therapy for the prevention of perinatal HIV. Abstract 289. Society for Maternal-Fetal Medicine Annual Meeting, Miami Beach, Florida, 2000
   Google Scholar
• International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type-1: a meta-analysis of 15 prospective cohort studies. New England Journal of Medicine 1999; 340: 977–987
   PubMed Web of Science ®Google Scholar
• Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. American Journal of Obstetrics and Gynecology 1997; 176: 478–489
   PubMed Web of Science ®Google Scholar
• Mofenson L M, Lambert J S, Stiehm E R. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. New England Journal of Medicine 1999; 341: 385–393
   PubMed Web of Science ®Google Scholar
• NPC. National Health and Social Demographic Survey. National Population Commission, AbujaNigeria 2004
   Google Scholar
• Nduati R, John G, Mbori Ngacha. Effect of breastfeeding and formula feeding on the transmission of HIV-1: a randomized trial. Journal of the American Medical Association 2000; 283: 1167–1174
   PubMed Web of Science ®Google Scholar
• Samelson R, Shapiro D, Tuamala E. HIV vertical transmission rates according to antiretroviral therapy and viral load during pregnancy among 347 mother-child pairs, 1998 – 1999 (PACTG 367). Abstract 276. Society for Maternal-Fetal Medicine Annual Meeting, Miami Beach, Florida, 2000
   Google Scholar
• UNAIDS/WHO. HIV/AIDS epidemic update. UNAIDS/WHO, Geneva 2002
   Google Scholar
• Van Dyke R B, Korber B T, Popek E, Macken C, Widmayer S M, Bardeguez A, et al. The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type-1 in the era of maternal antiretroviral therapy. Journal of Infectious Diseases 1999; 179: 319–328
   PubMed Web of Science ®Google Scholar
• WHO. A Guideline for the use of Antiretroviral Drugs in low resource areas. World Health Organisation, Geneva 2004
   Google Scholar
• Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995; 8: 506–510
   PubMedGoogle Scholar